Arrowhead Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.About ARWR
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.
CEOChristopher Richard Anzalone
CEOChristopher Richard Anzalone
Employees609
Employees609
HeadquartersPasadena, California
HeadquartersPasadena, California
Founded1989
Founded1989
Employees609
Employees609
ARWR Key Statistics
Market cap3.24B
Market cap3.24B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume2.59M
Average volume2.59M
High today$26.99
High today$26.99
Low today$25.80
Low today$25.80
Open price$26.27
Open price$26.27
Volume1.66M
Volume1.66M
52 Week high$39.83
52 Week high$39.83
52 Week low$17.05
52 Week low$17.05
ARWR News
TipRanks 6d
Arrowhead Pharmaceuticals Faces Distribution Risks with Vanscoy RelianceArrowhead Pharmaceuticals, Inc. (ARWR) has disclosed a new risk, in the Sales & Marketing category. Don't Miss our Black Friday Offers: Unlock your investing p...
Simply Wall St 7d
Insiders Sold US$1.6m Of Arrowhead Pharmaceuticals Stock Possibly Sending Warning SignEven though Arrowhead Pharmaceuticals, Inc. ( ) stock gained 13% last week, insiders who sold US$1.6m worth of stock over the past year are probably better off....
Analyst ratings
64%
of 14 ratingsBuy
64.3%
Hold
35.7%
Sell
0%